| HOME >> MEDICINE >> TECHNOLOGY |
303,349945,880Long-term investments
1,199,6724,429,140Deferred tax assets
117,122122,872Total assets
$20,851,403$22,290,813Liabilities and Shareholders' EquityCurrent liabilities:Accounts payable
$507,183$593,585Current portion – deferred rent
35,00035,000Income tax payable
7,09817,892Accrued liabilities:Compensation
1,822,4121,576,147Other
346,851316,995Total current liabilities
2,718,5442,539,619Deferred rent – less current portion
14,40542,043Accrued pension liability
475,232474,396Total liabilities
3,208,1813,056,058Total shareholders' equity
17,643,22219,234,755Total liabilities and shareholders' equity
$20,851,403$22,290,813
UROPLASTY, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)Nine Months EndedDecember 3120122011Cash flows from operating activities:Net loss
$(2,336,205)$(3,677,332)Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization
864,227832,309 Loss on disposal of equipment
3,0356,475 Amortization of premium on marketable securities
39,55127,210 Share-based consulting expense
1,6234,125 Share-based compensation expense
608,953498,906 Deferred income tax expense (benefit)
5,473(4,698) Deferred rent credit
(27,638)(26,421) Changes in operating assets and liabilities: Accounts receivable, net
228,768(374,068) Inventories
(138,862)(146,058) Other current assets
(70,401)(106,156) Accounts payable
(82,514)(82,491) Accrued liabilities
267,083356,589 Accrued pension liability, net
5,074(25,428)Net cash used in operating activities
(631,
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2012 PR Newswire. All rights reserved |